Showing results (61-70 of 261) with videos related to
Sort By:
Pageof 27
Cancer|August 28, 2003
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicityJonathan W Friedberg, Donna Neuberg, Helen Kim, et al.Annals of Internal Medicine|July 1, 2014
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort studyJane C Weeks, Hajime Uno, Nathan Taback, et al.Clinical Lymphoma, Myeloma & Leukemia|May 1, 2016
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin LymphomaPatrick M Reagan, Andrea Baran, Jennifer L Kelly, et al.Molecular Cancer Therapeutics|July 14, 2011
Carfilzomib interacts synergistically with histone deacetylase inhibitors in mantle cell lymphoma cells in vitro and in vivoGirija Dasmahapatra, Dmitry Lembersky, Minkyeong P Son, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2016
Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736Deborah M Stephens, Hongli Li, Michael L LeBlanc, et al.International Journal of Radiation Oncology, Biology, Physics|July 31, 2016
Patterns and Timing of Failure for Diffuse Large B-Cell Lymphoma After Initial Therapy in a Cohort Who Underwent Autologous Bone Marrow Transplantation for RelapseSughosh Dhakal, James E Bates, Carla Casulo, et al.Clinical Lymphoma, Myeloma & Leukemia|September 29, 2018
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin LymphomaRachel J David, Andrea Baran, Kah Poh Loh, et al.Nature Communications|October 14, 2018
EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcriptionEdward Ayoub, Michael P Wilson, Kathleen E McGrath, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphomaTithi Biswas, Eva Culakova, Jonathan W Friedberg, et al.Journal of Geriatric Oncology|July 31, 2021
Development and validation of a prediction model for 1-year mortality among older adults with Hodgkin Lymphoma who receive dose-intense chemotherapyAnita J Kumar, Jason Nelson, Angie Mae Rodday, et al.Pageof 27